About Zinc finger protein 879
Zinc finger protein 879 (ZNF879) is a protein
from Homo sapiens identified by UniProt accession
B4DU55, 563 residues long.
MolForge cross-references it against 0 known binders and
8 disease associations.
Target properties
| Protein name | Zinc finger protein 879 |
| UniProt accession | B4DU55 |
| Gene | ZNF879 |
| Organism | Homo sapiens |
| Length | 563 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (8)
Diseases linked to this target (Open Targets).
- body fat distribution · score 0.06
- FEV/FVC ratio · score 0.05
- cortical thickness · score 0.04
- alkaline phosphatase measurement · score 0.04
- body height · score 0.03
- BMI-adjusted waist circumference · score 0.03
- waist-hip ratio · score 0.02
- oral squamous cell carcinoma · score 0.00
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-B4DU55-F1 | alphafold | PREDICTED | 70.60 | — |
Amino-acid sequence (563 residues)
MARRLLPAHV QESVTFRDVA VFFSQDEWLH LDSAQRALYR EVMLENYSIL VSLGILFSKP KVISQLEQGE DPWMVESGVP QGAHLGWESL FGTIVSKEEN QEVMKKLIID GTFDFKLEKT YINEDKLEKQ QGKKNRLFSK VLVTIKKVYM KERSFKGVEF GKNLGLKSSL IRKPRIVSRG RRPRSQQYSV LFKQLGVNTV RKCYKCNICG KIFLHSSSLS KHQRIHTGEK LYKCKECRKA FSQSSSLTQH LRVHTGEKPY ICSECGKAFS FTTSLIGHQR MHTGERPYKC KECGKTFKGS SSLNNHQRIH TGEKPYKCNE CGRAFSQCSS LIQHHRIHTG EKPYECTQCG KAFTSISRLS RHHRIHTGEK PFHCNECGKV FSYHSALIIH QRIHTGEKPY ACKECGKAFS QSSALIQHQR IHTGEKPYKC NECGKAFSWI SRLNIHHRIH TGEKPYNCKE CGKAFSSHSG VNTHRKIHTG EKPYKCNDCE KAFNQSSALI QHQRIHTGEK PYNCKVCGKA FRQSSSLMTH MRIHTGEKPY KCKECGKAFS QSSSLTNHQR THN
Explore Zinc finger protein 879 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets